Will the FDA give emergency use authorization or otherwise approve Paxlovid before 2022?

This market will resolve to “Yes” if, by December 31, 2021, 11:59:59 PM ET, Paxlovid (also known under PF-07321332), or any product containing PF-07321332 receives an Emergency Use Authorization (EUA) or full approval from the FDA for treating COVID-19. Otherwise, this market will resolve to “No.” If the resolution source isn’t updated by the resolution date, credible news reports may be used instead. Learn more about Paxlovid: https://apnews.com/article/coronavirus-pandemic-science-business-health-medication-eeea3c6a5f6428479e35bc1bcd7aec52.